PUB - Publikationen an der Universität Bielefeld

Alle markieren

• [5]
  

  2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186

  Shao S, Scholtz L-U, Gendreizig S, Martínez-Ruiz L, Florido J, Escames G, Schürmann M, Hain C, Hose L, Mentz A, Schmidt P, Wang M, Goon P, Wehmeier M, Brasch F, Kalinowski J, Oppel F, Sudhoff H (2023)
  Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
  BMC Cancer 23(1): 47.

  PUB | PDF | DOI | WoS | PubMed | Europe PMC
   
• [4]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718

  Oppel F, Shao S, Gendreizig S, Kühnel P, Przybycin V, Hain C, Schmidt P, Schürmann M, Goon P, Niehaus K, Kalinowski J, Sudhoff H (2022)
  Head and neck cancer cells can differentiate and resemble their tissue of origin.
  In: Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA. Cancer Research, 82. American Association for Cancer Research (AACR): 111-111.

  PUB | DOI | WoS
   
• [3]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816

  Gendreizig S, Neumann JM, Loganathan L, Hose L, Goon P, Oppel F, Brasch F, Niehaus K, Sudhoff H (2022)
  P35 Spatial proteomics and metabolomics investigations in head & neck cancers.
  Oral Oncology 134: 106164.

  PUB | DOI | WoS
   
• [2]
  

  2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817

  Oppel F, Gendreizig S, Kühnel P, Martínez-Ruiz L, Shao S, Schmidt P, Hain C, Schürmann M, Hose L, Pabla H, Loganathan L, Viyof Ful F, Przybycin V, Scholtz L-U, Brasch F, Busche T, Goon P, Escames G, Niehaus K, Kalinowski J, Sudhoff H (2022)
  P28 Head and neck cancer cells differentiate resembling their tissue of origin.
  In: Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management. Amsterdam University Medical Centers (Ed); Oral Oncology, 134. Elsevier .

  PUB | DOI | WoS
   
• [1]
  

  2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703

  Oppel F, Shao S, Gendreizig S, Zimmerman MW, Schürmann M, Viyof Ful F, Goon P, Chi SN, Aster JC, Sudhoff H, Look AT (2022)
  p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition.
  Molecular Cancer Therapeutics.

  PUB | DOI | WoS | PubMed | Europe PMC